What Happens to SHBG Levels in PCOS?

What Happens to SHBG Levels in PCOS?

In PCOS, SHBG is almost always low — often 40–60% below the reference range for women without the condition. This drop frees up more testosterone and DHT to act on your tissues, making androgen symptoms like acne, hirsutism, and hair thinning significantly worse. The main exception: women with PCOS who are lean and insulin-sensitive tend to have higher SHBG and milder androgenic symptoms.

---

What Is SHBG and Why Does It Matter in PCOS?

SHBG (sex hormone-binding globulin) is a glycoprotein produced primarily by the liver. Its job is to bind sex hormones — testosterone, DHT, and estradiol — and carry them through the bloodstream in an inactive form. Only the unbound, or "free," fraction of a hormone can enter cells, activate receptors, and produce biological effects. When SHBG is low, the free fraction of testosterone and DHT rises even if your total testosterone looks normal on a standard panel.

This distinction matters enormously in PCOS. A woman can have a total testosterone in the normal range and still experience severe androgenic symptoms if her SHBG is suppressed enough to push free testosterone above the threshold where symptoms appear. Researchers have long recognized that free androgen index (FAI = total testosterone ÷ SHBG × 100) is a more reliable marker of androgen excess in PCOS than total testosterone alone (Diamanti-Kandarakis & Dunaif, Endocrine Reviews 2012; PMID: 22798666).

The liver synthesizes SHBG in response to several hormonal signals. Estrogen and thyroid hormones stimulate production; insulin, androgens, and growth hormone suppress it. In PCOS, most of those suppressive signals are elevated simultaneously, which explains why SHBG can fall so sharply.

---

Why Does SHBG Drop in PCOS? The Insulin Connection

Insulin is the primary driver of low SHBG in PCOS. Even modest hyperinsulinemia — blood insulin levels that are elevated but not yet diabetic — directly suppresses hepatic SHBG gene transcription. A landmark study by Plymate et al. established the dose-response relationship: as insulin rises, SHBG falls in a predictable, concentration-dependent way (Plymate et al., Journal of Clinical Endocrinology & Metabolism 1988; PMID: 3366246). More recent work confirmed that in women with PCOS, fasting insulin explains a larger portion of SHBG variance than androgen levels do, meaning insulin resistance is the upstream cause rather than a secondary effect.

A 2010 study of 156 women with PCOS found that SHBG levels correlated inversely with HOMA-IR (a standard index of insulin resistance) far more strongly than with total testosterone, BMI, or LH/FSH ratio (Lerchbaum et al., European Journal of Endocrinology 2010). This finding has practical implications: treating the insulin resistance is often more effective at raising SHBG than directly targeting androgens.

Body fat distribution compounds the problem. Visceral adipose tissue — the fat stored deep in the abdomen — secretes inflammatory cytokines and drives further insulin resistance. This is why weight gain around the middle is so common in PCOS and why it tends to be self-reinforcing: more visceral fat → more insulin resistance → lower SHBG → more free androgens → further fat redistribution driven by androgens. Breaking this cycle requires addressing insulin sensitivity directly.

Androgenic suppression of SHBG adds a second layer. Testosterone itself down-regulates hepatic SHBG production, creating a feedback loop: low SHBG raises free testosterone, which suppresses more SHBG, which raises free testosterone further. This is why SHBG can fall so rapidly in women with PCOS who experience a weight gain event or a period of high chronic stress.

---

How Stress Makes Low SHBG Worse in PCOS

Chronic stress is an underappreciated amplifier of androgen excess in PCOS. The adrenal glands, when chronically activated by psychological or physiological stress, produce elevated DHEA-S — an androgen precursor that can be converted peripherally to testosterone and DHT. Elevated DHEA-S is present in approximately 20–30% of PCOS cases and represents a distinct adrenal phenotype (Carmina et al., Fertility and Sterility 2006; PMID: 16494875).

Cortisol itself also suppresses SHBG at the hepatic level, independent of insulin. This means that a high-stress period can lower your SHBG through two pathways simultaneously: direct cortisol-mediated suppression and indirect adrenal androgen elevation. If you notice that your PCOS symptoms — acne, hair shedding, cycle irregularity — flare during stressful periods, this is likely why. Managing HPA axis dysregulation is not optional in PCOS; it is part of addressing the root hormonal environment.

If you want to understand how adrenal androgens interact with PCOS specifically, the DHEA-S data in PCOS is worth reviewing alongside your SHBG numbers.

Practical stress-reduction strategies that have measurable effects on cortisol and downstream androgen markers include:

1. Resistance training 3× per week — improves insulin sensitivity and has been shown to reduce fasting insulin by 15–20% in PCOS cohorts over 12 weeks, which indirectly supports SHBG recovery.
2. Sleep prioritization (7–9 hours) — cortisol dysregulation is exacerbated by sleep debt; even partial sleep restriction elevates morning cortisol.
3. Adaptogenic support — Ashwagandha (KSM-66 extract, 600 mg/day) has been shown in a randomized controlled trial of 64 adults to reduce serum cortisol by 27.9% versus placebo over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).

---

PCOS, Weight, and the SHBG Recovery Protocol

One of the most consistent findings in PCOS research is that even modest weight loss — 5–10% of body weight — produces a meaningful increase in SHBG. A meta-analysis of lifestyle intervention trials in PCOS found that weight reduction was associated with significant increases in SHBG alongside reductions in free androgen index, with improvements appearing within 3–6 months of sustained caloric deficit (Lim et al., Human Reproduction Update 2019; doi: 10.1093/humupd/dmz006).

The mechanism is straightforward: weight loss reduces visceral fat, lowers fasting insulin, reduces adrenal androgen output, and allows hepatic SHBG synthesis to recover. The type of weight loss matters somewhat — caloric restriction combined with resistance training produces greater insulin sensitization than aerobic exercise alone, which translates to faster SHBG recovery.

Dietary composition also influences SHBG independently of weight. High dietary fiber intake is associated with higher SHBG levels in population studies, likely because fiber reduces postprandial insulin spikes. Conversely, diets high in refined carbohydrates and saturated fat suppress SHBG. Low-glycemic eating patterns — not necessarily low-carbohydrate — consistently outperform standard diets in PCOS trials for improving both SHBG and menstrual regularity.

For more on the metabolic consequences of PCOS that compound SHBG suppression, the data on HbA1c and insulin resistance in PCOS and what causes abdominal weight gain in PCOS provide useful context.

---

When Low SHBG Has a Non-PCOS Cause: Ruling Out Tumors and Other Drivers

Not every case of low SHBG in a woman with suspected PCOS is caused by insulin resistance and androgen excess alone. Androgen-secreting tumors of the ovary or adrenal gland can produce severe SHBG suppression with a clinical picture that overlaps with PCOS but requires completely different management. Red flags that warrant urgent investigation include: very rapid onset of androgenic symptoms over weeks rather than months, total testosterone above 150–200 ng/dL, or DHEA-S in the frankly elevated range (above 700 µg/dL in most lab references).

Practitioners use pelvic ultrasound and adrenal imaging alongside a detailed hormone panel to distinguish PCOS from tumor-driven hyperandrogenism. If a tumor is identified and removed, SHBG can normalize dramatically — sometimes within weeks — because the primary androgen source has been eliminated. This is a fundamentally different trajectory than the gradual SHBG recovery seen with lifestyle and pharmacological management of PCOS.

Other less dramatic but meaningful causes of low SHBG that can coexist with or mimic PCOS include hypothyroidism (thyroid hormone normally stimulates hepatic SHBG production, so low thyroid → lower SHBG), non-alcoholic fatty liver disease, and use of androgenic medications including certain progestins in combined oral contraceptives.

Always work with your healthcare provider to rule out these confounders before attributing low SHBG entirely to PCOS. A comprehensive hormone panel that includes TSH, free T4, prolactin, fasting insulin, and DHEA-S — alongside total and free testosterone — provides the context needed for accurate interpretation.

---

What Normal SHBG Looks Like in PCOS vs. Without It

Reference ranges for SHBG in women of reproductive age typically run from about 18 to 144 nmol/L, a wide range that reflects how substantially SHBG varies with body composition, age, and hormonal status. In women with PCOS, median SHBG in published cohorts consistently falls in the 20–40 nmol/L range — often at the lower quarter of the reference interval or below it entirely. For a detailed breakdown of what specific SHBG values mean in a PCOS context, the reference range data for SHBG in PCOS is a useful companion read.

For clinical decision-making, many endocrinologists use a free androgen index above 4–5 as a diagnostic threshold for significant androgen excess, even when total testosterone is within range. A woman with total testosterone of 55 ng/dL (normal) and SHBG of 18 nmol/L has a FAI well above 5 and will typically have symptomatic androgen excess.

---

What This Means for Your Formula

Ones formulates personalized supplement plans based on blood work, wearable data, and health history — and for women with PCOS, the ingredients most relevant to the SHBG picture are selected based on your specific findings rather than a generic PCOS template.

Ashwagandha (KSM-66, 600 mg/day): For women whose low SHBG is being driven or amplified by HPA axis dysregulation and elevated cortisol, KSM-66 ashwagandha has a direct evidence base. The Chandrasekhar 2012 RCT (PMID: 23439798) showed a 27.9% reduction in serum cortisol over 60 days. Reducing cortisol load removes one of the suppressors of hepatic SHBG synthesis, and Ones includes this exact extract at the 600 mg clinical dose when adrenal support is indicated.

Ones Endocrine Support blend: This proprietary blend is formulated to address the hormonal environment underlying conditions like PCOS — supporting insulin signaling pathways and hormonal balance at the hepatic and adrenal level. For women where hormone panel findings suggest both androgen excess and dysregulated insulin, this blend is a core component of the formula.

Magnesium (as Magnesium Glycinate): Magnesium deficiency is highly prevalent in insulin-resistant states and directly impairs insulin receptor signaling. Restoring magnesium adequacy improves insulin sensitivity — one of the core upstream levers for SHBG recovery. Ones uses the glycinate form for its superior bioavailability and GI tolerability, dosed to clinically meaningful ranges based on your individual labs.

Because Ones analyzes your actual numbers — not a symptom checklist — the formula adjusts based on whether your SHBG suppression looks adrenal-driven, insulin-driven, or a combination of both. That specificity is what generic PCOS supplement stacks cannot replicate.

---

Key Takeaways

• SHBG is almost universally low in PCOS, often 40–60% below reference range, which amplifies free testosterone and DHT activity even when total testosterone looks normal.
• Insulin resistance is the primary driver: hyperinsulinemia directly suppresses hepatic SHBG gene transcription; treating insulin resistance is typically more effective than targeting androgens directly.
• Chronic stress adds a second suppressive pathway via cortisol and adrenal androgens (DHEA-S), which is why symptom flares during stressful periods are physiologically predictable.
• Even 5–10% weight loss restores SHBG meaningfully through reduced visceral fat, lower fasting insulin, and improved hepatic function — dietary fiber and low-glycemic eating support this independently of weight change.
• Rule out non-PCOS causes — androgen-secreting tumors, hypothyroidism, and fatty liver disease can all suppress SHBG and require different management approaches.
• Targeted supplement support — particularly adaptogens proven to reduce cortisol and nutrients that improve insulin signaling — can complement lifestyle changes, but should be based on your actual lab values, not a generic PCOS protocol.